by Gem

We work side by side with SMEs, research centers and international Companies that are looking for innovative and customized solutions for Research and Development, in compliance with the current regulations. Together we may solve safety, efficacy and quality problems arising during product development. LIFESCIENCES PHARMACEUTICAL A fully comprehensive support in the development of non-clinical studies may be provided, from the discovery phase to the first in human (FIH) phase. We supply essential bioanalytical aid to carry out clinical trials, from phase I to phase III. Explore LIFESCIENCES MED TECH We offer analytical and technical support in the development and validation of medical devices and in vitro diagnostics. Based on our experience in drug development, we can foster the characterization and successful development of food supplements and nutraceuticals. Explore LIFESCIENCES AGRIFOOD Biosecurity studies for innovative agrochemicals and novel foods may be performed, along with the identification of new biomarkers to consistently guarantee the high quality of the products.
Explore

PLATFORMS

Gem Forlab operates on three integrated platforms, designed to offer customized solutions to perfectly meet our customers’ needs.

IMCB



Immunoenzymatic assays, Molecular and Cell Biology

IMCB

Advanced immunometric, molecular and cell biology technologies are already available to create and develop new assays. Our expertise is particularly strong in the field of detection of large molecules in complex matrices, analysis of mechanisms of action, characterization of biological activity and target validation, thus ensuring accurate and reliable results. The Gem Forlab team may provide suitable advice about the best materials and reagents for the development of new biological assays (ELISA, RT-PCR, q-PCR, cell based assays), securing that each step is complying with the highest quality standards. We are ready to properly support those who choose us at each stage of the innovation process.

MSPP



Mass spectrometry, proteomics and analytical chemistry

MSPP

Mass spectrometry combined to liquid chromatography (LC-MS) is applied to develop new analytical methods for the detection of small molecules in complex matrices and for the identification and isolation of impurities from raw materials, intermediates, active ingredients and food supplements. We are experts in the identification of proteins, including biomarkers, through the analysis of the proteome. Comprehensive support is offered for pre-clinical studies, with the assessment of safety, efficacy and distribution of the drug substance in complex matrices, aiming at ensuring the highest standards of quality and accuracy at every stage of the project.

CONSULTANCY



Preclinical Development and Regulatory Strategy

CONSULTANCY

We support biotech and pharmaceutical companies in the early stages of drug development through an integrated approach that combines scientific consultancy, experimental planning and regulatory strategy. Preliminary screenings are conducted based on analysis of the scientific literature and available data, with experimental studies designed to be optimised in terms of time and cost. We provide comprehensive support for the preparation of IND authorisation, ensuring compliance with GLP/GMP guidelines, with the aim of reducing development risks and accelerating project progress.

QUALITY AND REGULATORY

We are a GLP certified and AIFA-recognized Testing Centre, listed in the OsSC register as a private laboratory qualified for the analysis of samples from clinical studies (phases I-II-III)

GLP CERTIFICATION

On September 9, 2022, our GLP certification was renewed for the following areas: physico-chemical tests; residue studies; biotechnology and molecular biology studies; pharmacokinetics (ADME) and toxicokinetics studies. All computerized systems and softwares are internally validated according to the requirements of regulatory authorities (US 21CFR Part11, GAMP guidelines).

GCP AUTHORIZATION

Since October 1st, 2014, we have been included in the OsSC register of private laboratories qualified for the analysis of samples from clinical trials on drugs (phases I-II-III) by the AIFA, conforming to articles 1 and 2 of the DM 16 Marzo 1998.
Find more

QUALITY MANAGEMENT SYSTEM

All activities of GEM FORLAB, not regulated otherwise, follow an internal quality management system inspired by the general principles of GLP.

PARTNERSHIP

Since 1980, Gem Chimica offers customized solutions in several sectors: professional cleaning, food safety management, environmental health, renewable energy, water treatment, chemical, physical and microbiological analysis.

 

The consultancy company specialising in regulatory toxicology, created to take your business far, shedding light on the complex and changing regulatory sea and helping you ensure the safety of the products you want to bring to market.

 

Galileo Research is a non-clinical Contract Research Organization (CRO). Our solutions meet global regulatory requirements and include studies on toxicology, biocompatibility, efficacy/performance and mechanisms of action.

 

Abich has been providing research and analysis services mainly to manufacturers of cosmetics, medical products. In addition, Abich provides, actively researches and promotes the validation of in-vitro methods as an alternative to animal testing, in line with current regulations. 

 

VETSPIN is a Contract Research Organization founded in 2004 as a spinoff of the University of Bologna. VETSPIN performs Pre-Clinical and Clinical trials for regulatory purposes in farm animals.

 

Fluody is a chemical Contract Research Organization (cCRO), located in Villanova Mondovì (CN), Italy. Our expertise is synthetic organic chemistry: we offer R&D services, process development, custom synthesis and contract manufacturing.

 

Since 2009, we have been the hub for the growth and success of Piedmont's health and life sciences value chain. Our network of excellence brings together key players in the world of innovation: we are a network that collaborates and produces value.

 

Bridge To Lab (B2L) is a spin-off from the University of Turin offering R&D services in the pharmaceutical, nutraceutical, dermocosmetic, and medical device sectors, operating within a non-certified preclinical setting.
This approach allows us to deliver highly customized solutions at competitive costs, by developing advanced biotechnological protocols and leveraging academic know-how through a network of specialized laboratories.
B2L is the ideal partner for companies seeking flexible, efficient, and high-quality innovation.